MedPath

Effects of Medical and Surgical Weight Loss on Metabolism

Completed
Conditions
Obesity
Type 2 Diabetes
Registration Number
NCT00592735
Lead Sponsor
Garvan Institute of Medical Research
Brief Summary

This study will follow ,morbidly obese subjects as they undertake weight loss before and after laparoscopic gastric banding, examining markers of glucose and lipid metabolism, adipokines and measures of body fat.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • morbidly obese subjects with type 2 diabetes or metabolic syndrome
  • age <70
Exclusion Criteria
  • contra-indications to bariatric surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
weight loss6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

St Vincent's Hospital

🇦🇺

Sydney, New South Wales, Australia

St Vincent's Hospital
🇦🇺Sydney, New South Wales, Australia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.